Characterization of heparin interactions with Clostridioides difficile toxins and its potential as anti-CDI therapeutics.|https://dx.doi.org/10.1016/j.carbpol.2024.123143
Clostridioides difficile Infections and Antibiotherapy: Results of Four Years of Observation in a Romanian Tertiary Hospital.|https://dx.doi.org/10.3390/microorganisms12122490
Study on the Efficacy and Safety of Tedizolid in Japanese Patients.|https://dx.doi.org/10.3390/antibiotics13121237
Access in all areas? A roundup of developments in market access and health technology assessment: part 6.|https://dx.doi.org/10.57264/cer-2024-0239
